In contemporary psychiatric research and alternative psychopharmacology, few compounds have generated as much intense scientific inquiry as ibogaine. Derived primarily from the root bark of the West African shrub Tabernanthe iboga, this complex indole alkaloid has historically been studied for its profound effects on interrupting substance use disorders and mitigating severe neurological trauma. However, emerging […]
The modern intersection of psychedelic science, clinical psychiatry, and global mental healthcare represents one of the most profound paradigm shifts in contemporary medicine. Across an international footprint spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, researchers, clinicians, and regulatory authorities are re-evaluating how naturally occurring […]